Literature DB >> 29082557

The nuclear DEK interactome supports multi-functionality.

Eric A Smith1, Eric F Krumpelbeck1, Anil G Jegga2, Malte Prell3, Marie M Matrka1, Ferdinand Kappes3,4, Kenneth D Greis5, Abdullah M Ali1, Amom R Meetei1, Susanne I Wells1.   

Abstract

DEK is an oncoprotein that is overexpressed in many forms of cancer and participates in numerous cellular pathways. Of these different pathways, relevant interacting partners and functions of DEK are well described in regard to the regulation of chromatin structure, epigenetic marks, and transcription. Most of this understanding was derived by investigating DNA-binding and chromatin processing capabilities of the oncoprotein. To facilitate the generation of mechanism-driven hypotheses regarding DEK activities in underexplored areas, we have developed the first DEK interactome model using tandem-affinity purification and mass spectrometry. With this approach, we identify IMPDH2, DDX21, and RPL7a as novel DEK binding partners, hinting at new roles for the oncogene in de novo nucleotide biosynthesis and ribosome formation. Additionally, a hydroxyurea-specific interaction with replication protein A (RPA) was observed, suggesting that a DEK-RPA complex may form in response to DNA replication fork stalling. Taken together, these findings highlight diverse activities for DEK across cellular pathways and support a model wherein this molecule performs a plethora of functions.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  DDX21; DEK; IMPDH2; RPA; interactome; mass spectrometry; ribosome

Mesh:

Substances:

Year:  2017        PMID: 29082557      PMCID: PMC5730476          DOI: 10.1002/prot.25411

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  55 in total

1.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

2.  Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.

Authors:  Eva Petermann; Manuel Luís Orta; Natalia Issaeva; Niklas Schultz; Thomas Helleday
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

3.  Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.

Authors:  Yingfu Ou; Rongjun Xia; Fanyong Kong; Xiaokang Zhang; Shengjin Yu; Lili Jiang; Linlin Zheng; Lijuan Lin
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

4.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

5.  Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.

Authors:  Xin Liu; Dongdong Qi; Jujie Qi; Zeshu Mao; Xiangdan Li; Jinhui Zhang; Jinzi Li; Wenbin Gao
Journal:  Oncol Rep       Date:  2015-10-30       Impact factor: 3.906

6.  GPS: a comprehensive www server for phosphorylation sites prediction.

Authors:  Yu Xue; Fengfeng Zhou; Minjie Zhu; Kashif Ahmed; Guoliang Chen; Xuebiao Yao
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

7.  The SAF-box domain of chromatin protein DEK.

Authors:  Friederike Böhm; Ferdinand Kappes; Ingo Scholten; Nicole Richter; Hiroshi Matsuo; Rolf Knippers; Tanja Waldmann
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

8.  Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis.

Authors:  Marie C Matrka; Miki Watanabe; Ranjithmenon Muraleedharan; Paul F Lambert; Andrew N Lane; Lindsey E Romick-Rosendale; Susanne I Wells
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.

Authors:  Eric A Smith; Bhavna Kumar; Kakajan Komurov; Stephen M Smith; Nicole V Brown; Songzhu Zhao; Pawan Kumar; Theodoros N Teknos; Susanne I Wells
Journal:  Oncotarget       Date:  2017-04-04

10.  DEK is required for homologous recombination repair of DNA breaks.

Authors:  Eric A Smith; Boris Gole; Nicholas A Willis; Rebeca Soria; Linda M Starnes; Eric F Krumpelbeck; Anil G Jegga; Abdullah M Ali; Haihong Guo; Amom R Meetei; Paul R Andreassen; Ferdinand Kappes; Lisa M Privette Vinnedge; Jeremy A Daniel; Ralph Scully; Lisa Wiesmüller; Susanne I Wells
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

View more
  7 in total

1.  The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.

Authors:  Magdalena Ganz; Christopher Vogel; Christina Czada; Vera Jörke; Eva Christina Gwosch; Rebecca Kleiner; Agnieszka Pierzynska-Mach; Francesca Cella Zanacchi; Alberto Diaspro; Ferdinand Kappes; Alexander Bürkle; Elisa Ferrando-May
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

2.  Sex-dependent and -independent transcriptional changes during haploid phase gametogenesis in the sugar kelp Saccharina latissima.

Authors:  Gareth A Pearson; Neusa Martins; Pedro Madeira; Ester A Serrão; Inka Bartsch
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

3.  Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.

Authors:  Zhe Chen; Dawei Huo; Lei Li; Zhilong Liu; Zhigang Li; Shuangnian Xu; Yongxiu Huang; Weiru Wu; Chengfang Zhou; Yuanyuan Liu; Mei Kuang; Feng Wu; Hui Li; Pengxu Qian; Guanbin Song; Xudong Wu; Jieping Chen; Yu Hou
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

Review 4.  Aptamers for Proteins Associated with Rheumatic Diseases: Progress, Challenges, and Prospects of Diagnostic and Therapeutic Applications.

Authors:  Elizaveta A Shatunova; Maksim A Korolev; Vitaly O Omelchenko; Yuliya D Kurochkina; Anna S Davydova; Alya G Venyaminova; Mariya A Vorobyeva
Journal:  Biomedicines       Date:  2020-11-22

5.  Downregulation of DEAD-box helicase 21 (DDX21) inhibits proliferation, cell cycle, and tumor growth in colorectal cancer via targeting cell division cycle 5-like (CDC5L).

Authors:  Kai Wang; Baosong Li; Peng Fan; Xiang Ren; Hong Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2.

Authors:  Emrah Özçelik; Ahmet Kalaycı; Büşra Çelik; Açelya Avcı; Hasan Akyol; İrfan Baki Kılıç; Türkan Güzel; Metin Çetin; Merve Tuzlakoğlu Öztürk; Zihni Onur Çalışkaner; Melike Tombaz; Dilan Yoleri; Özlen Konu; Ayten Kandilci
Journal:  PLoS One       Date:  2022-10-03       Impact factor: 3.752

Review 7.  NUP214 in Leukemia: It's More than Transport.

Authors:  Adélia Mendes; Birthe Fahrenkrog
Journal:  Cells       Date:  2019-01-21       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.